Cellectar Biosciences: A Shoestring Chance You will Miss (NASDAQ: CLRB)

Missed Putt

woraput/E+ by means of Getty Images

Topline Summary

Cellectar Biosciences ( NASDAQ: CLRB) is a long-toothed developmental biotech concentrated on the advancement of a radiolabeled phospholipid for the management of hematologic malignancies, with Waldenstrom’s macroglobulinemia being their primary shot on objective. Really just recently, they had

Like this post? Please share to your friends:
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: